Histamine Toxicity Market Size

  • Report ID: 5462
  • Published Date: Nov 26, 2025
  • Report Format: PDF, PPT

Histamine Toxicity Market Outlook:

Histamine Toxicity Market size was valued at USD 440.18 million in 2025 and is set to exceed USD 737.76 million by 2035, expanding at over 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of histamine toxicity is estimated at USD 461.18 million.

The growth in this market can be driven by an increase in consumption of seafood such as canned fish and the risk associated with its exposure to H.A.T. toxicity. According to estimates, 80% of fish consumed in the United States is imported from another country. It can also be said that the toxicity of histamine is intimately related to fish trade from all over the world.

The histamine toxicity market driven by a lack of internationally harmonized safety standards and awareness about the diseases associated with it. The development of the market for histamine toxicity is likely to be driven by a sufficient level of knowledge among food industry professionals regarding refrigeration and processing. In particular, people are not aware that expiry dates can be regarded as an important factor when buying food for cold storage. This is due to the lack of awareness, they occur more frequently in low-income countries.


Histamine Toxicity Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of histamine toxicity is estimated at USD 461.18 million.

The global histamine toxicity market size was around USD 440.18 million in 2025 and is likely to expand at a CAGR of more than 5.3%, surpassing USD 737.76 million revenue by 2035.

North America is anticipated to capture a 33% revenue share by 2035, driven by high seafood consumption and growing awareness of histamine intolerance.

Key players in the market include Travere Therapeutics, Inc., Alembic pharmaceuticals, Intas Pharmaceuticals Ltd, Sanofi Aventis Ltd, Cipla Limited, Actavis Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos